S19-533 Use of Small Molecule Inhibitor for Preventing Abdominal Adhesions Researchers at Stanford have identified a novel method of use for the drug T-5224 in the prevention of abdominal adhesion. Michael Longaker Gerlinde Wernig Jeffrey Norton Geoffrey Gurtner Michael Januszyk Deshka Foster Malini Chinta
S20-364 New Immunotherapeutic Target for the Treatment of Lung Cancer and Fibrotic Lung Diseases Stanford scientists have discovered a new immunotherapeutic target for treating lung cancer and fibrotic lung disease. Gerlinde Wernig Tristan Lerbs Lu Cui Qiwen Deng Cristabelle De Souza
S19-434 Combinatorial Antibody Blockade of IL6 and PD-1/CD47 as Lung Fibrosis Treatment and Adjunct Cancer Immunotherapy Technology summary Gerlinde Wernig